These aren't just companiesโthey're the architects of tomorrow's markets. Each stock has been carefully selected by our expert analysts for their ability to create entirely new industries, setting the standards that followers must imitate.
These aren't just successful companiesโthey're the originators that establish entirely new categories others rush to imitate. Getting in early with true innovators could mean capturing growth at its source.
The commercialization of artificial intelligence is creating a perfect environment for these innovators to extend their lead. Many are positioned to launch next-generation products that could reshape their industries.
These companies aren't just part of the futureโthey're actively creating it. By investing in the architects of tomorrow's markets, you're potentially securing a front-row seat to where the economy is heading.
We've focused on companies that don't just participate in marketsโthey create them. These pioneering firms invent transformative technologies and business models that competitors are forced to follow, from smartphones to streaming services to cloud computing.
These market-makers typically benefit from substantial growth potential as they secure early market share, build powerful brand loyalty, and define industry standards. Many are currently positioned to capitalize on AI commercialization and technological sovereignty trends.
Each company was selected based on their proven history of disruptive innovation, significant R&D investments, and robust intellectual property portfolios. They represent the foundational players that are actively shaping future economic landscapes.
Market capitalisation breakdown for the 'True Innovators' basket, showing total market cap and individual holdings.
AAPL: $3.90T
GOOGL: $3.03T
AMZN: $2.37T
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+7
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+24.26%
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 24.26% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 17๊ฐ ์ค 13๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
